Mikhailova Alexandra, Jylhä Antti, Rieck Jochen, Nättinen Janika, Ilmarinen Tanja, Veréb Zoltán, Aapola Ulla, Beuerman Roger, Petrovski Goran, Uusitalo Hannu, Skottman Heli
BioMediTech, University of Tampere, Finland.
Department of Ophthalmology, School of Medicine, University of Tampere, Finland.
Sci Rep. 2015 Oct 1;5:14684. doi: 10.1038/srep14684.
Limbal epithelial stem cells (LESCs) are tissue-specific stem cells responsible for renewing the corneal epithelium. Acute trauma or chronic disease affecting LESCs may disrupt corneal epithelial renewal, causing vision threatening and painful ocular surface disorders, collectively referred to as LESC deficiency (LESCD). These disorders cannot be treated with traditional corneal transplantation and therefore alternative cell sources for successful cell-based therapy are needed. LESCs derived from human pluripotent stem cells (hPSCs) are a prospective source for ocular surface reconstruction, yet critical evaluation of these cells is crucial before considering clinical applications. In order to quantitatively evaluate hPSC-derived LESCs, we compared protein expression in native human corneal cells to that in hPSC-derived LESCs using isobaric tag for relative and absolute quantitation (iTRAQ) technology. We identified 860 unique proteins present in all samples, including proteins involved in cell cycling, proliferation, differentiation and apoptosis, various LESC niche components, and limbal and corneal epithelial markers. Protein expression profiles were nearly identical in LESCs derived from two different hPSC lines, indicating that the differentiation protocol is reproducible, yielding homogeneous cell populations. Their protein expression profile suggests that hPSC-derived LESCs are similar to the human ocular surface epithelial cells, and possess LESC-like characteristics.
角膜缘上皮干细胞(LESCs)是负责更新角膜上皮的组织特异性干细胞。影响LESCs的急性创伤或慢性疾病可能会破坏角膜上皮更新,导致威胁视力和引起疼痛的眼表疾病,统称为角膜缘上皮干细胞缺乏症(LESCD)。这些疾病无法通过传统的角膜移植进行治疗,因此需要用于成功的细胞治疗的替代细胞来源。源自人多能干细胞(hPSCs)的LESCs是眼表重建的潜在来源,但在考虑临床应用之前,对这些细胞进行严格评估至关重要。为了定量评估hPSC衍生的LESCs,我们使用相对和绝对定量的等压标签(iTRAQ)技术比较了天然人角膜细胞与hPSC衍生的LESCs中的蛋白质表达。我们在所有样本中鉴定出860种独特的蛋白质,包括参与细胞周期、增殖、分化和凋亡的蛋白质、各种LESCs生态位成分以及角膜缘和角膜上皮标志物。来自两种不同hPSC系的LESCs中的蛋白质表达谱几乎相同,表明分化方案具有可重复性,可产生均匀的细胞群体。它们的蛋白质表达谱表明,hPSC衍生的LESCs类似于人眼表上皮细胞,并具有LESCs样特征。